Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 20 of 448

1.

Safety and effectiveness of long-term use of darbepoetin alfa in non-dialysis patients with chronic kidney disease: a post-marketing surveillance study in Japan.

Tanaka T, Nangaku M, Imai E, Tsubakihara Y, Kamai M, Wada M, Asada S, Akizawa T.

Clin Exp Nephrol. 2018 Sep 4. doi: 10.1007/s10157-018-1632-9. [Epub ahead of print]

PMID:
30182223
2.

Association between serum Na-Cl level and renal function decline in chronic kidney disease: results from the chronic kidney disease Japan cohort (CKD-JAC) study.

Maruta Y, Hasegawa T, Yamakoshi E, Nishiwaki H, Koiwa F, Imai E, Hishida A.

Clin Exp Nephrol. 2018 Aug 24. doi: 10.1007/s10157-018-1631-x. [Epub ahead of print]

PMID:
30168046
3.

Correction to: Risk factors for increased left ventricular hypertrophy in patients with chronic kidney disease: findings from the CKD-JAC study.

Nitta K, Iimuro S, Imai E, Matsuo S, Makino H, Akizawa T, Watanabe T, Ohashi Y, Hishida A.

Clin Exp Nephrol. 2018 Aug 9. doi: 10.1007/s10157-018-1624-9. [Epub ahead of print]

PMID:
30094596
4.

Risk factors for increased left ventricular hypertrophy in patients with chronic kidney disease: findings from the CKD-JAC study.

Nitta K, Iimuro S, Imai E, Matsuo S, Makino H, Akizawa T, Watanabe T, Ohashi Y, Hishida A.

Clin Exp Nephrol. 2018 Jun 27. doi: 10.1007/s10157-018-1605-z. [Epub ahead of print] Erratum in: Clin Exp Nephrol. 2018 Aug 9;:.

PMID:
29951723
5.

Regional variations in immunosuppressive therapy in patients with primary nephrotic syndrome: the Japan nephrotic syndrome cohort study.

Yamamoto R, Imai E, Maruyama S, Yokoyama H, Sugiyama H, Nitta K, Tsukamoto T, Uchida S, Takeda A, Sato T, Wada T, Hayashi H, Akai Y, Fukunaga M, Tsuruya K, Masutani K, Konta T, Shoji T, Hiramatsu T, Goto S, Tamai H, Nishio S, Shirasaki A, Nagai K, Yamagata K, Hasegawa H, Yasuda H, Ichida S, Naruse T, Fukami K, Nishino T, Sobajima H, Tanaka S, Akahori T, Ito T, Yoshio T, Katafuchi R, Fujimoto S, Okada H, Ishimura E, Kazama JJ, Hiromura K, Mimura T, Suzuki S, Saka Y, Sofue T, Suzuki Y, Shibagaki Y, Kitagawa K, Morozumi K, Fujita Y, Mizutani M, Shigematsu T, Kashihara N, Sato H, Matsuo S, Narita I, Isaka Y.

Clin Exp Nephrol. 2018 Apr 20. doi: 10.1007/s10157-018-1579-x. [Epub ahead of print]

PMID:
29679356
6.
7.

Anaemia is an essential complication of ANCA-associated renal vasculitis: a single center cohort study.

Kawamura T, Usui J, Kaneko S, Tsunoda R, Imai E, Kai H, Morito N, Saito C, Nagata M, Yamagata K.

BMC Nephrol. 2017 Nov 25;18(1):337. doi: 10.1186/s12882-017-0754-8.

8.

An objective evaluation of nocturnal cough count and cough pattern in children with psychogenic cough.

Imai E, Hirai K, Mikami Y, Nukaga M, Enseki M, Tabata H, Kato M, Mochizuki H.

Respir Investig. 2017 Nov;55(6):334-337. doi: 10.1016/j.resinv.2017.08.008. Epub 2017 Oct 21. Review.

PMID:
29153413
9.

Retraction Note to: Risk factors for increased left ventricular hypertrophy in patients with chronic kidney disease.

Nitta K, Iimuro S, Imai E, Matsuo S, Makino H, Akizawa T, Watanabe T, Ohashi Y, Hishida A.

Clin Exp Nephrol. 2017 Dec;21(6):1146. doi: 10.1007/s10157-017-1466-x. No abstract available.

PMID:
28889397
10.

Erratum to: Rationale and design of oBservational clinical Research In chronic kidney disease patients with renal anemia: renal proGnosis in patients with Hyporesponsive anemia To Erythropoiesis-stimulating agents, darbepoetiN alfa (BRIGHTEN Trial).

Kato H, Nangaku M, Hirakata H, Wada T, Hayashi T, Sato H, Yamazaki Y, Masaki T, Kagimura T, Yamamoto H, Hase H, Kamouchi M, Imai E, Mizuno K, Iwasaki M, Akizawa T, Tsubakihara Y, Maruyama S, Narita I.

Clin Exp Nephrol. 2018 Feb;22(1):85-86. doi: 10.1007/s10157-017-1461-2. No abstract available.

PMID:
28875480
11.

A lung sound analysis in a child thought to have cough variant asthma: A case report.

Imai E, Enseki M, Nukaga M, Tabata H, Hirai K, Kato M, Mochizuki H.

Allergol Int. 2018 Jan;67(1):150-152. doi: 10.1016/j.alit.2017.06.004. Epub 2017 Jun 30. No abstract available.

12.

Rationale and design of oBservational clinical Research In chronic kidney disease patients with renal anemia: renal proGnosis in patients with Hyporesponsive anemia To Erythropoiesis-stimulating agents, darbepoetiN alfa (BRIGHTEN Trial).

Kato H, Nangaku M, Hirakata H, Wada T, Hayashi T, Sato H, Yamazaki Y, Masaki T, Kagimura T, Yamamoto H, Hase H, Kamouchi M, Imai E, Mizuno K, Iwasaki M, Akizawa T, Tsubakihara Y, Maruyama S, Narita I.

Clin Exp Nephrol. 2018 Feb;22(1):78-84. doi: 10.1007/s10157-017-1427-4. Epub 2017 Jun 28. Erratum in: Clin Exp Nephrol. 2017 Sep 5;:.

13.
14.

Different Psychosocial Factors Are Associated With Different Intention and Self-Efficacy Toward Eating Breakfast Among Japanese Breakfast Skippers.

Nakade M, Tsubota-Utsugi M, Imai E, Tsuboyama-Kasaoka N, Nishi N, Takimoto H.

Asia Pac J Public Health. 2017 Mar;29(2):102-113. doi: 10.1177/1010539517691092. Epub 2017 Feb 15.

PMID:
28201941
15.

Sodium chloride promotes tissue inflammation via osmotic stimuli in subtotal-nephrectomized mice.

Sakata F, Ito Y, Mizuno M, Sawai A, Suzuki Y, Tomita T, Tawada M, Tanaka A, Hirayama A, Sagara A, Wada T, Maruyama S, Soga T, Matsuo S, Imai E, Takei Y.

Lab Invest. 2017 Apr;97(4):432-446. doi: 10.1038/labinvest.2017.4. Epub 2017 Feb 6.

16.
17.

Cardiovascular events and death in Japanese patients with chronic kidney disease.

Tanaka K, Watanabe T, Takeuchi A, Ohashi Y, Nitta K, Akizawa T, Matsuo S, Imai E, Makino H, Hishida A; CKD-JAC Investigators.

Kidney Int. 2017 Jan;91(1):227-234. doi: 10.1016/j.kint.2016.09.015. Epub 2016 Nov 22.

18.

Mizoribine therapy combined with steroids and mizoribine blood concentration monitoring for idiopathic membranous nephropathy with steroid-resistant nephrotic syndrome.

Saito T, Iwano M, Matsumoto K, Mitarai T, Yokoyama H, Yorioka N, Nishi S, Yoshimura A, Sato H, Ogahara S, Sasatomi Y, Kataoka Y, Ueda S, Koyama A, Maruyama S, Nangaku M, Imai E, Matsuo S, Tomino Y; Refractory Nephrotic Syndrome Study Group.

Clin Exp Nephrol. 2017 Dec;21(6):961-970. doi: 10.1007/s10157-016-1340-2. Epub 2016 Oct 25.

19.

Clinical practice guideline for drug-induced kidney injury in Japan 2016: digest version.

Usui J, Yamagata K, Imai E, Okuyama H, Kajiyama H, Kanamori H, Kaneko S, Kono E, Sakai Y, Sakai N, Sakamaki Y, Taniguchi Y, Nakai K, Nishiwaki H, Hirata S, Yamaya H, Tsuruoka S, Terada Y, Yokoyama H, Wada T, Narita I.

Clin Exp Nephrol. 2016 Dec;20(6):827-831. Review. No abstract available.

20.

The physical examination content of the Japanese National Health and Nutrition Survey: temporal changes.

Tanaka H, Imai S, Nakade M, Imai E, Takimoto H.

Asia Pac J Clin Nutr. 2016 Dec;25(4):898-910. doi: 10.6133/apjcn.092015.34.

Supplemental Content

Loading ...
Support Center